Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21895950 | 1.00 | RNASEL (0.49) | RNASELPOLB | |
| SCHEMBL17948732 | 1.00 | RNASEL (0.49) | RNASELPOLB | |
| SCHEMBL22765983 | 0.94 | TERT (0.48) | RNASELPOLB | |
| SCHEMBL22765945 | 0.94 | TERT (0.48) | RNASELPOLB | |
| SCHEMBL25582525 | 0.91 | RNASEL (0.57) | RNASELPOLB | |
| SCHEMBL16979764 | 0.91 | POLB (0.59) | RNASELPOLB | |
| SCHEMBL29420330 | 0.91 | POLB (0.59) | RNASELPOLB | |
| SCHEMBL31606440 | 0.91 | POLB (0.59) | RNASELPOLB | |
| SCHEMBL30665600 | 0.91 | POLB (0.59) | RNASELPOLB | |
| SCHEMBL16983787 | 0.91 | POLB (0.59) | RNASELPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230069218-A1 | METHOD FOR PRODUCING PEPTIDE CONTAINING NON-NATURAL AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-03-02 | — | — | US | disclosed |
| US-20210061860-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2021-03-04 | — | — | US | disclosed |
| EP-3424941-A1 | PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME | Chugai Seiyaku Kabushiki Kaisha (JP) | 2019-01-09 | — | — | EP | disclosed |
| US-20150080549-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-03-19 | — | — | US | disclosed |
| US-20150080549-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230069218-A1 | METHOD FOR PRODUCING PEPTIDE CONTAINING NON-NATURAL AMINO ACID | MRPL21, RPL41, RPL21 | RNASEL 570/4885POLB 1665/4885 |
| US-20210061860-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | RNASEL 3269/4885POLB 4572/4885 |
| US-20150080549-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | RNASEL 3269/4885POLB 4572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.